Back to Search

JASON SLAKTER, MD

MD

Ophthalmology Physician

NPI: 1275562084IndividualAccepts Medicare

Specialties, Licenses & Credentials

Specialist

Specialist

Code: 174400000X

1587031(NY)
Ophthalmology PhysicianPrimary

Ophthalmology

Code: 207W00000X

158703-1(NY)

CMS Specialties

PrimaryOPHTHALMOLOGY

Education

ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY

Class of 1983

Research & Publications (20)

The Digital Angiography Reading Center (DARC) role in the anecortave acetate clinical trials.
PMID 17240261·Surv Ophthalmol·2007
6-review
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
PMID 16368146·Ophthalmology·2006
4-observational
Anecortave acetate for treating or preventing choroidal neovascularization.
PMID 16935212·Ophthalmol Clin North Am·2006
6-review
Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.
PMID 10768338·Ophthalmology·2000
8-other
Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
PMID 19243834·Ophthalmology·2009
8-other
Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
PMID 18929354·Am J Ophthalmol·2009
3-trial
Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes.
PMID 19541286·Am J Ophthalmol·2009
8-other
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.
PMID 18329624·Am J Ophthalmol·2008
5-case
Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration.
PMID 18625940·Arch Ophthalmol·2008
8-other
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study.
PMID 18036873·Am J Ophthalmol·2007
3-trial
Diagnostic and therapeutic challenges.
PMID 17558329·Retina·2007
5-case
Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
PMID 17891004·Retina·2007
8-other
Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration.
PMID 17891007·Retina·2007
8-other
Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study.
PMID 16963851·Retina·2006
3-trial
Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab.
PMID 17031300·Retina·2006
5-case
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
PMID 16508427·Retina·2006
8-other
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
PMID 16603955·Retina·2006
8-other
Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
PMID 16963850·Retina·2006
2-rct
Large spot transpupillary thermotherapy for occult choroidal neovascularization.
PMID 16157814·Arch Ophthalmol·2005
8-other
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
PMID 16157822·Arch Ophthalmol·2005
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
950 THIRD AVENUE, 3RD FLOOR
NEW YORK, NY 10022

Location

Practice Location

950 THIRD AVENUE, NEW YORK, NY
(212) 861-9797

Quick Facts

NPI
1275562084
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
43
Publications
20

Are you this provider?

Claim Your Profile